Literature DB >> 3279116

Separation and comparison of two monokines with lymphocyte-activating factor activity: IL-1 beta and hybridoma growth factor (HGF). Identification of leukocyte-derived HGF as IL-6.

J Van Damme1, J Van Beeumen, B Decock, J Van Snick, M De Ley, A Billiau.   

Abstract

Supernatants of mitogen-stimulated human leukocytes contain two biologically related cytokines, IL-1 and hybridoma growth factor (HGF). IL-1 beta is a potent inducer of HGF in fibroblasts but has little stimulating effect on monocytes that spontaneously produce HGF. Leukocyte-derived HGF and IL-1 were separated by the use of affinity chromatography on specific antibodies and discriminating assay systems for both cytokines. They had different Mr upon gel filtration and SDS-PAGE. In contrast to IL-1 beta, HGF showed heterogeneity on a cation-exchange column. IL-1 beta and HGF were purified to homogeneity by a sequence of four and five purification steps, respectively. Leukocyte-derived HGF was characterized by analysis of its NH2-terminal amino acid sequence. This revealed complete homology with fibroblast-derived HGF, 26-kDa protein, IFN-beta 2, and B cell stimulatory factor 2, molecules which have collectively been designated as IL-6. IL-1 beta exerted an antiviral and growth-promoting effect of fibroblasts, whereas HGF/IL-6 did not. Both IL-1 and IL-6 possessed lymphocyte-activating factor activity, which could be neutralized only by an anti-serum against the corresponding cytokine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3279116

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  Interleukin-6 and the acute phase response.

Authors:  P C Heinrich; J V Castell; T Andus
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

2.  Cytokine regulation of immunoglobulin secretion by neonatal lymphocytes.

Authors:  J B Splawski; P E Lipsky
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

3.  Interleukin-6 and renal cell cancer: production, regulation, and growth effects.

Authors:  A S Koo; C Armstrong; B Bochner; T Shimabukuro; C L Tso; J B deKernion; A Belldegrum
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

Review 4.  Chemoattractants and cytokines in primary ciliary dyskinesia and cystic fibrosis: key players in chronic respiratory diseases.

Authors:  Maaike Cockx; Mieke Gouwy; Jo Van Damme; Sofie Struyf
Journal:  Cell Mol Immunol       Date:  2017-11-27       Impact factor: 11.530

5.  Platelet-activating factor stimulates interleukin-6 production by human endothelial cells and synergizes with tumor necrosis factor for enhanced production of granulocyte-macrophage colony stimulating factor.

Authors:  C Lacasse; S Turcotte; D Gingras; J Stankova; M Rola-Pleszczynski
Journal:  Inflammation       Date:  1997-04       Impact factor: 4.092

Review 6.  IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation.

Authors:  B E Barton
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

7.  Human appendix B cells naturally express receptors for and respond to interleukin 6 with selective IgA1 and IgA2 synthesis.

Authors:  K Fujihashi; J R McGhee; C Lue; K W Beagley; T Taga; T Hirano; T Kishimoto; J Mestecky; H Kiyono
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

8.  Unresponsiveness of CD4-8+/- thymocytes to lectin stimulation in LEC mutant rats.

Authors:  T Sakai; T Agui; K Wei; M Oka; H Hisaeda; H Nagasawa; K Himeno; K Matsumoto; W Kaichun
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

9.  Tonic inhibition of chemotaxis in human plasma.

Authors:  Stephen E Malawista; Anne de Boisfleury Chevance; Jo van Damme; Charles N Serhan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-07       Impact factor: 11.205

10.  PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia.

Authors:  Sofie Struyf; Evemie Schutyser; Mieke Gouwy; Klara Gijsbers; Paul Proost; Yves Benoit; Ghislain Opdenakker; Jo Van Damme; Geneviève Laureys
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.